MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$3,731,100K
Net Income
$298,700K
Net Profit Margin
8.01%
EPS
$3.64
Unit: Thousand (K) dollars
Revenue Breakdown
Diagnostics-Operating Segments
Biopharma Laboratory Services-Op...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
3,731,100
3,537,600
3,515,800
3,563,500
Cost of revenues
2,619,100
2,523,800
2,522,600
2,538,400
Gross profit
1,112,000
1,013,800
993,200
1,025,100
Selling, general, and administrative expenses
577,200
551,000
538,600
552,400
Amortization of intangibles and other assets
78,100
75,600
72,600
69,500
Asset impairment charges
-
-
3,600
700
Restructuring and other charges
5,100
6,400
110,800
5,900
Operating income
451,600
380,800
267,600
396,600
Interest expense
61,100
55,100
55,000
56,000
Investment income
5,600
12,200
3,500
3,500
Equity method loss, net
-6,200
-5,100
-6,100
-5,200
Other, net
-3,500
-13,100
-19,400
-1,900
Earnings from operations before income taxes
386,400
319,700
190,600
337,000
Provision for income taxes
87,300
41,700
25,700
75,500
Earnings from continuing operations
-
-
164,900*
-
Earnings from discontinued operations, net of tax
-
-
0*
-
Net earnings
299,100
278,000
164,900
261,500
Less net earnings attributable to the noncontrolling interest
400
200
200
400
Net earnings attributable to labcorp holdings inc
298,700
277,800
164,700
261,100
Basic EPS
3.66
3.37
1.992
3.14
Diluted EPS
3.64
3.35
1.977
3.12
Basic Average Shares
81,700,000
82,300,000
82,700,000
83,100,000
Diluted Average Shares
82,000,000
82,900,000
83,300,000
83,700,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Diagnostics-Operating Segments
$2,900,700K
(5.53%↑ Y/Y)
Biopharma Laboratory
Services-Operating Segments
$836,200K
(6.55%↑ Y/Y)
Revenues
$3,731,100K
(5.78%↑ Y/Y)
Intersegment Elimination
-$5,800K
(7.94%↑ Y/Y)
Gross profit
$1,112,000K
(6.29%↑ Y/Y)
Cost of revenues
$2,619,100K
(5.56%↑ Y/Y)
Operating income
$451,600K
(14.47%↑ Y/Y)
Investment income
$5,600K
(229.41%↑ Y/Y)
Selling, general, and
administrative expenses
$577,200K
(-0.36%↓ Y/Y)
Amortization of intangibles
and other assets
$78,100K
(14.35%↑ Y/Y)
Restructuring and other
charges
$5,100K
(24.39%↑ Y/Y)
Earnings from operations
before income taxes
$386,400K
(26.81%↑ Y/Y)
Interest expense
$61,100K
(7.01%↑ Y/Y)
Equity method loss, net
-$6,200K
(-264.71%↓ Y/Y)
Other, net
-$3,500K
(89.30%↑ Y/Y)
Net earnings
$299,100K
(25.51%↑ Y/Y)
Provision for income taxes
$87,300K
(31.48%↑ Y/Y)
Net earnings
attributable to labcorp...
$298,700K
(25.56%↑ Y/Y)
Less net earnings
attributable to the...
$400K
(0.00%↑ Y/Y)
Buy us a coffee
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)